| Eugen Catalin Minca, MD | |
|
2155 City Gate Ln, Naperville, IL 60563-7733 | |
| (630) 469-9200 | |
| Not Available |
| Full Name | Eugen Catalin Minca |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 22 Years |
| Location | 2155 City Gate Ln, Naperville, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861790362 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZD0900X | Pathology - Dermatopathology | 036.140228 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward Hospital | Naperville, IL | Hospital |
| Elmhurst Memorial Hospital | Elmhurst, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Associated Pathologists And Laboratory Physicians Llc | 0446582175 | 12 |
| Dupage Medical Group Ltd | 5496667941 | 1209 |
| Laboratory And Pathology Diagnostics Llc | 4486630886 | 13 |
| Oak Dermatology Llc | 7810256849 | 14 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.
Muscle Flex Inc. (www.MuscleFlex.com) announced today that it will attend Gridlock's (www.gridlockla.com) New Years Eve at the Legendary Paramount Pictures Studio in Los Angeles with Adam Lambert headlining the event to ring in the New Decade.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
All animals, including humans, have an internal 24-hour clock or circadian rhythm that creates a daily oscillation of body temperature, brain activity, hormone production and metabolism.
› Verified 1 days ago
| Entity Name | Dupage Medical Group Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20031110000535 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.
Muscle Flex Inc. (www.MuscleFlex.com) announced today that it will attend Gridlock's (www.gridlockla.com) New Years Eve at the Legendary Paramount Pictures Studio in Los Angeles with Adam Lambert headlining the event to ring in the New Decade.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
All animals, including humans, have an internal 24-hour clock or circadian rhythm that creates a daily oscillation of body temperature, brain activity, hormone production and metabolism.
› Verified 1 days ago
| Entity Name | Laboratory & Pathology Diagnostics Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285713826 PECOS PAC ID: 4486630886 Enrollment ID: O20040626000144 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.
Muscle Flex Inc. (www.MuscleFlex.com) announced today that it will attend Gridlock's (www.gridlockla.com) New Years Eve at the Legendary Paramount Pictures Studio in Los Angeles with Adam Lambert headlining the event to ring in the New Decade.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
All animals, including humans, have an internal 24-hour clock or circadian rhythm that creates a daily oscillation of body temperature, brain activity, hormone production and metabolism.
› Verified 1 days ago
| Entity Name | Oak Dermatology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487168258 PECOS PAC ID: 7810256849 Enrollment ID: O20180118002702 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.
Muscle Flex Inc. (www.MuscleFlex.com) announced today that it will attend Gridlock's (www.gridlockla.com) New Years Eve at the Legendary Paramount Pictures Studio in Los Angeles with Adam Lambert headlining the event to ring in the New Decade.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
All animals, including humans, have an internal 24-hour clock or circadian rhythm that creates a daily oscillation of body temperature, brain activity, hormone production and metabolism.
› Verified 1 days ago
| Entity Name | Associated Pathologists And Laboratory Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568903565 PECOS PAC ID: 0446582175 Enrollment ID: O20191030002562 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.
Muscle Flex Inc. (www.MuscleFlex.com) announced today that it will attend Gridlock's (www.gridlockla.com) New Years Eve at the Legendary Paramount Pictures Studio in Los Angeles with Adam Lambert headlining the event to ring in the New Decade.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
All animals, including humans, have an internal 24-hour clock or circadian rhythm that creates a daily oscillation of body temperature, brain activity, hormone production and metabolism.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eugen Catalin Minca, MD 1860 Paysphere Cir, Chicago, IL 60674-0018 Ph: (630) 469-9200 | Eugen Catalin Minca, MD 2155 City Gate Ln, Naperville, IL 60563-7733 Ph: (630) 469-9200 |
News Archive
Radiology and cardiovascular researchers from the Medical University of South Carolina in Charleston, S.C., today present new data that shows the risk of cancer from exposure to radiation during computed tomography for cardiovascular disease has been overstated and that new estimates are several times lower than previously published conclusions.
Interlace Medical, Inc., today announced that it has initiated a multi-center clinical trial of the MyoSure Hysteroscopic Tissue Removal System. The purpose of this study is to demonstrate that women experience minimal to no pain or discomfort during a MyoSure procedure, when given a mild oral sedative together with a local anesthetic injected into the cervix.
Muscle Flex Inc. (www.MuscleFlex.com) announced today that it will attend Gridlock's (www.gridlockla.com) New Years Eve at the Legendary Paramount Pictures Studio in Los Angeles with Adam Lambert headlining the event to ring in the New Decade.
QRxPharma announced today the successful outcome of a Phase 1 trial for MoxDuo CR, a controlled-release (CR) Dual-Opioid(TM) designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic pain (including cancer, lower back, osteoarthritis and neuropathic). The purpose of the trial was to determine which of the various experimental formulations provided the optimum duration of drug levels in the blood.
All animals, including humans, have an internal 24-hour clock or circadian rhythm that creates a daily oscillation of body temperature, brain activity, hormone production and metabolism.
› Verified 1 days ago
Dr. Karl Michael Napekoski, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S. Washington Street, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Sarah B Clark, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Richard R Anderson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Theodore E Troe, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Cathryn A Goldberg, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Rohit Gupta, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 | |
Dwight W Morrow, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 801 S Washington Street, Edward Hospital, Naperville, IL 60566 Phone: 630-355-0450 Fax: 630-527-3911 |